Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R-Bridge Healthcare Fund is a healthcare-focused private credit and royalty financing platform affiliated with CBC Group. It provides bespoke, non-dilutive financing to biotech, biopharma, medtech, and healthcare services companies, typically backed by royalties, revenue interests, and other healthcare product cash flows rather than developing therapeutics itself. Founded in 2020, R-Bridge has positioned itself as Asia's first healthcare-dedicated structured financing fund and has expanded through a second fund focused on global healthcare private credit opportunities. Its transactions have included financing for companies such as Trevena, Mirxes, and Human Investments to support commercialization and market expansion. The entity is best characterized as a healthcare investment vehicle rather than an operating drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R-Bridge Healthcare.